Mirae Asset Global Etfs Holdings Ltd. 89bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 51,154 shares of ETNB stock, worth $430,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,154
Previous 49,985
2.34%
Holding current value
$430,716
Previous $369,000
6.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ETNB
# of Institutions
173Shares Held
125MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$139 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$119 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$85.9 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$63 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$59.1 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $391M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...